Patents by Inventor Yurie AKIMOTO

Yurie AKIMOTO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DRUG SUBSTANCE OF LEMBOREXANT AND MEDICINAL COMPOSITION COMPRISING SAME
    Publication number: 20230103250
    Abstract: There is provided a pharmaceutical composition comprising lemborexant exhibiting a favorable dissolution profile by using a granular material having a 90% cumulative diameter (D90) of 64 ?m or less as a lemborexant active pharmaceutical ingredient.
    Type: Application
    Filed: January 14, 2021
    Publication date: March 30, 2023
    Inventors: Taichi ABE, Yusuke AYATA, Nobuya SUZUKI, Yurie AKIMOTO, Futoshi SHIKATA, Yasuhiro Zaima, Nobuo YOSHIDA
  • Compositions and methods for treating insomnia
    Patent number: 11026944
    Abstract: In the present invention, compound such as (1R,2S)-2-(((2,4-dimethylpyrimidin-5-yl)oxy)methyl)-2-(3-fluorophenyl)-N-(5-fluoropyridin-2-yl) cyclopropanecarboxamide have been found to be potent orexin receptor antagonists, and may be useful in the treatment of sleep disorders such as insomnia, as well as for other therapeutic uses.
    Type: Grant
    Filed: March 16, 2020
    Date of Patent: June 8, 2021
    Assignee: Eisai R&D Management Co., Ltd.
    Inventors: Margaret Moline, Gina Pastino, Yurie Akimoto, Yasuhiro Zaima, Nobuya Suzuki, Nobuo Yoshida
  • COMPOSITIONS AND METHODS FOR TREATING INSOMNIA
    Publication number: 20200268754
    Abstract: In the present invention, compound such as (1R,2S)-2-(((2,4-dimethylpyrimidin-5-yl)oxy)methyl)-2-(3-fluorophenyl)-N-(5-fluoropyridin-2-yl) cyclopropanecarboxamide have been found to be potent orexin receptor antagonists, and may be useful in the treatment of sleep disorders such as insomnia, as well as for other therapeutic uses.
    Type: Application
    Filed: March 16, 2020
    Publication date: August 27, 2020
    Applicant: Eisai R&D Management Co., Ltd.
    Inventors: Margaret MOLINE, Gina PASTINO, Yurie AKIMOTO, Yasuhiro ZAIMA, Nobuya SUZUKI, Nobuo YOSHIDA
  • Compositions and methods for treating insomnia
    Patent number: 10702529
    Abstract: In the present invention, compound such as (1R,2S)-2-(((2,4-dimethylpyrimidin-5-yl)oxy)methyl)-2-(3-fluorophenyl)-N-(5-fluoropyridin-2-yl) cyclopropanecarboxamide have been found to be potent orexin receptor antagonists, and may be useful in the treatment of sleep disorders such as insomnia, as well as for other therapeutic uses.
    Type: Grant
    Filed: January 23, 2019
    Date of Patent: July 7, 2020
    Assignee: Eisai R&D Management Co., Ltd.
    Inventors: Margaret Moline, Gina Pastino, Yurie Akimoto, Yasuhiro Zaima, Nobuya Suzuki, Nobuo Yoshida
  • COMPOSITIONS AND METHODS FOR TREATING INSOMNIA
    Publication number: 20190201399
    Abstract: In the present invention, compound such as (1R,2S)-2-(((2,4-dimethylpyrimidin-5-yl)oxy)methyl)-2-(3-fluorophenyl)-N-(5-fluoropyridin-2-yl)cyclopropanecarboxamide have been found to be potent orexin receptor antagonists, and may be useful in the treatment of sleep disorders such as insomnia, as well as for other therapeutic uses.
    Type: Application
    Filed: January 23, 2019
    Publication date: July 4, 2019
    Applicant: Eisai R&D Management Co., Ltd.
    Inventors: Margaret MOLINE, Gina PASTINO, Yurie AKIMOTO, Yasuhiro ZAIMA, Nobuya SUZUKI, Nobuo YOSHIDA
  • Compositions and methods for treating insomnia
    Patent number: 10188652
    Abstract: In the present invention, compound such as (1R,2S)-2-(((2,4-dimethylpyrimidin-5-yl)oxy)methyl)-2-(3-fluorophenyl)-N-(5-fluoropyridin-2-yl) cyclopropanecarboxamide have been found to be potent orexin receptor antagonists, and may be useful in the treatment of sleep disorders such as insomnia, as well as for other therapeutic uses.
    Type: Grant
    Filed: October 21, 2015
    Date of Patent: January 29, 2019
    Assignee: Eisai R&D Management Co., Ltd.
    Inventors: Margaret Moline, Gina Pastino, Yurie Akimoto, Yasuhiro Zaima, Nobuya Suzuki, Nobuo Yoshida
  • COMPOSITIONS AND METHODS FOR TREATING INSOMNIA
    Publication number: 20170252342
    Abstract: In the present invention, compound such as (1R,2S)-2-(((2,4-dimethylpyrimidin-5-yl)oxy)methyl)-2-(3-fluorophenyl)-N-(5-fluoropyridin-2-yl) cyclopropanecarboxamide have been found to be potent orexin receptor antagonists, and may be useful in the treatment of sleep disorders such as insomnia, as well as for other therapeutic uses.
    Type: Application
    Filed: October 21, 2015
    Publication date: September 7, 2017
    Applicant: Eisai R&D Management Co., Ltd.
    Inventors: Margaret MOLINE, Gina PASTINO, Yurie AKIMOTO, Yasuhiro ZAIMA, Nobuya SUZUKI, Nobuo YOSHIDA